Study S000252

SEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY®

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05897398
Acronym: SEMASEARCH
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 1100
Start: 2024-06-10
Primary completion: 2025-06-10
Lead sponsor: Hospices Civils de Lyon
Conditions: Obesity; Bariatric Surgery; Binge Eating Disorder; Syndromic Obesity; Sarcopenic Obesity; Iatrogenic Obesity; Psychotropic Drugs
Interventions: OTHER:Data collection; OTHER:Blood sampling; OTHER:Questionnaires
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Weight trends in patients included in the SEMASEARCH cohort at initiation and 12 months of treatment with WEGOVY®. [At initiation of treatment and 12 month of treatment]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0006210	GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders. Guo J, The Journal of neuroscience : the official journal of the Society for Neuroscience	2025	Nonrandomized study	PMID 41224657 DOI	cites ClinicalTrials.gov:NCT05897398; registry reference DERIVED:41224657